Colorado Bill Would Shield So-Called Orphan Drugs From Pricing Caps

Colorado Bill Would Shield So-Called Orphan Drugs From Pricing Caps The measure is facing pushback because it has the potential to ensnare FDA-approved medications prescribed for common conditions that also are used to treat rare diseases. Plus, news on Medicaid cuts and conversion therapy. https://kffhealthnews.org/morning-breakout/colorado-bill-would-shield-so-called-orphan-drugs-from-pricing-caps/